Nucleotide-binding oligomerization domain protein 2 deficiency enhances neointimal formation in response to vascular injury

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 31, Issue 11, 2011, Pages 2441-2447

  Kwon, Min Young ^a   Liu, Xiaoli ^c   Lee, Seon Jin ^c   Kang, Young Ho ^a   Choi, Augustine M K ^c   Lee, Ki Up ^b   Perrella, Mark A ^c,d   Chung, Su Wol ^a,c  

^a University of Ulsan   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Divisions of Pulmonary and Critical Care Medicine   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

nucleotide binding oligomerization domain protein 2; restenosis; smooth muscle cells; vascular biology; vascular injury

Indexed keywords

BOVINE SERUM ALBUMIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; MURAMYL DIPEPTIDE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; SMOOTH MUSCLE ACTIN; STRESS ACTIVATED PROTEIN KINASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMORAL ARTERY; MOUSE; NEOINTIMA; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; SMOOTH MUSCLE; SMOOTH MUSCLE FIBER; VASCULAR ARTERIAL OBSTRUCTIVE DISEASE; VASCULAR BIOLOGY; VASCULAR SMOOTH MUSCLE CELL;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; AORTA; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; FEMORAL ARTERY; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, ANIMAL; MUSCLE, SMOOTH, VASCULAR; NEOINTIMA; NOD2 SIGNALING ADAPTOR PROTEIN; PLATELET-DERIVED GROWTH FACTOR; RNA, SMALL INTERFERING;

EID: 80054906775     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.111.235135     Document Type: Article

References (34)

1. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP. Association of NOD2 LRR variants with susceptibility to Crohn's disease. Nature. 2001; 411:599-603. (Pubitemid 32531408)
2. Ogura Y, Bonen DK, Inohara N, Nicolae L, Chen FF. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411:603-606. (Pubitemid 32531409)
3. Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A. NOD2 is a general sensor of peptidoglycan through MDP detection. J Biol Chem. 2003;278:8869-8872. (Pubitemid 36800360)
4. Rosenstiel P, Kuhbacher T, Seegert D, Schreiber S. TNF-and IFN-Bregulate the expression of the NOD2 in human intestinal epithelial cells. Gastroenterology. 2003;124:1001-1009. (Pubitemid 36389803)
5. Lala S, Ogura Y, Osborne C, Hor SY, Bromfield A, Davies S, Ogunbiyi O, Nunez G, Keshav S. Crohn's disease and the NOD2 gene: a role for paneth cells. Gastroenterology. 2003;125:47-57. (Pubitemid 36799106)
6. Stroh T, Batra A, Glauben R, Bereswill S, Siegmund B. NOD1 and 2: regulation of expression and function in preadipocytes. J Immunol. 2008; 181:3620-3627.
7. Hirao K, Yumoto H, Nakanishi T, Matsuo T. Roles of TLR2, TLR4, and NOD2 in pulp fibroblasts. J Dent Res. 2009;88:762-767.
8. Hosokawa I, Hosokawa Y, Ozaki K, Yumoto H, Nakae H, Matsuo T. Proinflammatory effects of MDP on human gingival fibroblasts. J Periodontal Res. 2010;45:193-199.
9. Davey MP, Martin TM, Planck SR, Lee J, Zamora D, Rosenbaum JT. Human endothelial cells express NOD2/CARD15 and increase IL-6 secretion in response to muramyl dipeptide. Microvasc Res. 2006;71: 103-107.
10. Oh HM, Lee HJ, Seo GS, Choi EY, Kweon SH, Chun CH, Han WC, Lee KM, Lee MS, Choi SC, Jun CD. Induction and localization of NOD2 protein in human endothelial cells. Cell Immunol. 2005;237:37-44.
11. Dzau VJ, Braun-Dullaeus RC, Sedding DG. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med. 2002;8:1249-1256. (Pubitemid 35373556)
12. Miyazawa K, Kikuchi S, Fukuyama J, Hamano S, Ujiie A. Inhibition of PDGF-and TGFAc1-induced collagen synthesis, migration and proliferation by tranilast in VSMCs from spontaneously hypertensive rats. Atherosclerosis. 1995;118:213-221. (Pubitemid 26011483)
13. Ronnstrand L, Heldin CH. Mechanisms of PDGF-induced chemotaxis. Int J Cancer. 2001;91:757-762.
14. Mahabeleshwar GH, Kundu GC. Syk suppresses the cell motility and NFAcB-mediated secretion of PA by inhibiting the PI3K activity in breast cancer cells. J Biol Chem. 2003;278:6209-6221.
15. Chow EK, O'Connell RM, Schilling S, Wang XF, Fu XY, Cheng G. TLR agonists regulate PDGF-BB production and cell proliferation through TGFAc/type I IFN crosstalk. EMBO J. 2005;24:4071-4081. (Pubitemid 41752876)
16. Edfeldt K, Swedenborg J, Hansson GK, Yan ZQ. Expression of TLRs in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation. 2002;105:1158-1161. (Pubitemid 34225814)
17. Michelsen KS, Wong MH, Shah PK, Zhang W, Yano J, Doherty TM, Akira S, Rajavashisth TB, Arditi M. Lack of TLR4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA. 2004;101: 10679-10684. (Pubitemid 38955802)
18. Mullick AE, Tobias PS, Curtiss LK. Modulation of atherosclerosis in mice by TLR2. J Clin Invest. 2005;115:3149-3156.
19. Vink A, Schoneveld AH, Van der Meer JJ, Van Middelaar BJ, Sluijter JPS, Smeets MB, Quax PHA, Lim SK, Borst C, Pasterkamp G, de Kleijn DPV. In vivo evidence for a role of TLR4 in the development of intimal lesions. Circulation. 2002;106:1985-1990. (Pubitemid 35176306)
20. Roque M, Fallon JT, Badimon JJ, Zhang WX, Taubman MB, Reis ED. Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler Thromb Vasc Biol. 2000;20:335-342. (Pubitemid 30086088)
21. Wei J, Gorman TE, Liu X, Ith B, Tseng X, Chen Z, Simon DI, Layne MD, and Yet SF. Increased neointima formation in CRP2-deficient mice in response to vascular injury. Circ Res. 2005;97:1323-13331.
22. Hu Y, Zou Y, Dietrich H, Wick G, Xu Q. Inhibition of neointima hyperplasia of mouse vein grafts by locally applied suramin. Circulation. 1999;100:861-868. (Pubitemid 29398886)
23. Chung SW, Chen YH, Perrella MA. Role of Ets-2 in the regulation of HO-1 by endotoxin. J Biol Chem. 2005;280:4578-4588.
24. Janeway CA Jr. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today. 1992;13:11-16.
25. Medzhitov R, Janeway CA Jr. Innate immunity: impact on the adaptive immune response. Curr Opin Immunol. 1997;9:4-9. (Pubitemid 27095892)
26. Medzhitov R, Janeway CA Jr. Decoding the patterns of self and nonself by the innate immune system. Science. 2002;296:298-300. (Pubitemid 34303673)
27. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010;464:104-107.
28. Gill R, Tsung A, Billiar T. Linking oxidative stress to inflammation: TLRs. Free Radic Biol Med. 2010;48:1121-1132.
29. Wright SD, Burton C, Hernandez M, Hassing H, Montenegro J, Mundt S, Patel S, Card DJ, Hermanowski-Vosatka A, Bergstrom JD, Sparrow CP, Detmers PA, Chao YS. Infectious agents are not necessary for murine atherogenesis. J Exp Med. 2000;191:1437-1442.
30. Cartwright N, Murch O, McMaster SK, PaulAclark MJ, Van Heel DA, Ryffel B, Quesniaux VF, Evans TW, Thiemermann C, Mitchell JA. Selective NOD1 agonists cause shock and organ injury/dysfunction in vivo. Am J Respir Crit Care Med. 2007;175:595-603. (Pubitemid 46438944)
31. Yang X, Coriolan D, Schultz K, Golenbock DT, Beasley D. TLR2 mediates persistent chemokine release by Chlamydia pneumoniaeinfected VSMCs. Arterioscler Thromb Vasc Biol. 2005;25:2308-2314. (Pubitemid 41552647)
32. Cole JE, Navin TJ, Cross AJ, Goddard ME, Alexopoulou L, Mitra AT, Davies AH, Flavell RA, Feldmann M, Monaco C. Unexpected protective role for TLR3 in the arterial wall. Proc Natl Acad Sci USA. 2011;108: 2372-2377.
33. Sabbah A, Chang TH, Harnack R, Frohlich V, Tominaga K, Dube PH, Xiang Y, Bose S. Activation of innate immune antiviral responses by NOD2. Nat Immunol. 2009;10:1073-1080.
34. Courivaud C, Ferrand C, Ducloux D. No evidence of association between NOD2 gene polymorphism and atherosclerotic events after renal transplantation. Transplantation. 2006;81:1212-1215.